...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

Someone scooped up 321,300 "ZHCLF" shares for 10 cents US per share on the OTC Market.

 

Koo

Share
New Message
Please login to post a reply